CNTX
Price
$0.81
Change
+$0.02 (+2.53%)
Updated
Feb 21 closing price
Capitalization
61.05M
24 days until earnings call
SYGGF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Feb 21 closing price
Capitalization
27.94M
Ad is loading...

CNTX vs SYGGF

Header iconCNTX vs SYGGF Comparison
Open Charts CNTX vs SYGGFBanner chart's image
Context Therapeutics
Price$0.81
Change+$0.02 (+2.53%)
Volume$90.03K
Capitalization61.05M
Synairgen
Price$0.04
Change-$0.00 (-0.00%)
Volume$17.5K
Capitalization27.94M
CNTX vs SYGGF Comparison Chart
Loading...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTX vs. SYGGF commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a Hold and SYGGF is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (CNTX: $0.81 vs. SYGGF: $0.04)
Brand notoriety: CNTX and SYGGF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 15% vs. SYGGF: 208%
Market capitalization -- CNTX: $61.05M vs. SYGGF: $27.94M
CNTX [@Biotechnology] is valued at $61.05M. SYGGF’s [@Biotechnology] market capitalization is $27.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whileSYGGF’s FA Score has 0 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • SYGGF’s FA Score: 0 green, 5 red.
According to our system of comparison, SYGGF is a better buy in the long-term than CNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 5 TA indicator(s) are bullish.

  • CNTX’s TA Score: 5 bullish, 3 bearish.

Price Growth

CNTX (@Biotechnology) experienced а -0.93% price change this week, while SYGGF (@Biotechnology) price change was -1.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

CNTX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTX($61M) has a higher market cap than SYGGF($27.9M). SYGGF YTD gains are higher at: 36.842 vs. CNTX (-22.476).
CNTXSYGGFCNTX / SYGGF
Capitalization61M27.9M219%
EBITDA-32.54MN/A-
Gain YTD-22.47636.842-61%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash84.8MN/A-
Total Debt244KN/A-
TECHNICAL ANALYSIS
Technical Analysis
CNTX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LBTYK11.910.03
+0.25%
Liberty Global Ltd
PPSI3.80-0.05
-1.30%
Pioneer Power Solutions
NPCE13.77-0.46
-3.23%
Neuropace
SSTK25.41-0.90
-3.42%
SHUTTERSTOCK
CDNS258.34-11.89
-4.40%
Cadence Design Systems

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and FATE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
+3.04%
FATE - CNTX
30%
Poorly correlated
-8.09%
DSGN - CNTX
29%
Poorly correlated
-2.00%
CMMB - CNTX
29%
Poorly correlated
-3.39%
HRMY - CNTX
27%
Poorly correlated
-0.95%
ELVN - CNTX
26%
Poorly correlated
+1.54%
More

SYGGF and

Correlation & Price change

A.I.dvisor tells us that SYGGF and INAB have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SYGGF and INAB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYGGF
1D Price
Change %
SYGGF100%
-1.02%
INAB - SYGGF
27%
Poorly correlated
-5.07%
ATNF - SYGGF
20%
Poorly correlated
-2.34%
AWKNF - SYGGF
15%
Poorly correlated
N/A
CNTX - SYGGF
3%
Poorly correlated
+3.04%
CING - SYGGF
2%
Poorly correlated
+0.95%
More